Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-07

Clinical Trial Update: Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas [EARLY_Phase 1]

View source ↗

Summary

A terminated early-phase 1 trial evaluated repurposed ketoconazole for glioblastoma, reporting on its neuro-pharmacological properties.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketoconazole (Ketoconazole)

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Glioblastoma, Glioblastoma Multiforme | EARLY_Phase 1 | Status: TERMINATED